A detailed history of Dorsey & Whitney Trust CO LLC transactions in Vericel Corp stock. As of the latest transaction made, Dorsey & Whitney Trust CO LLC holds 9,015 shares of VCEL stock, worth $473,107. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,015
Previous 9,270 2.75%
Holding current value
$473,107
Previous $425,000 10.59%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.25 - $53.56 $10,773 - $13,657
-255 Reduced 2.75%
9,015 $380,000
Q1 2024

May 09, 2024

SELL
$32.52 - $52.33 $43,219 - $69,546
-1,329 Reduced 12.54%
9,270 $482,000
Q3 2023

Nov 08, 2023

SELL
$31.69 - $39.25 $855 - $1,059
-27 Reduced 0.25%
10,599 $355,000
Q1 2023

May 11, 2023

BUY
$23.85 - $31.34 $5,247 - $6,894
220 Added 2.11%
10,626 $311,000
Q4 2022

Feb 09, 2023

SELL
$17.65 - $27.37 $4,694 - $7,280
-266 Reduced 2.49%
10,406 $274,000
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $241,400 - $347,266
10,672 New
10,672 $247,000
Q2 2022

Aug 12, 2022

SELL
$22.88 - $39.45 $174,254 - $300,451
-7,616 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$31.69 - $43.29 $25,415 - $34,718
802 Added 11.77%
7,616 $291,000
Q3 2021

Nov 10, 2021

BUY
$46.35 - $59.75 $132,375 - $170,646
2,856 Added 72.16%
6,814 $333,000
Q2 2021

Aug 11, 2021

SELL
$47.2 - $67.81 $113,752 - $163,422
-2,410 Reduced 37.85%
3,958 $208,000
Q1 2021

May 11, 2021

SELL
$30.93 - $59.48 $72,376 - $139,183
-2,340 Reduced 26.87%
6,368 $354,000
Q4 2020

Feb 05, 2021

BUY
$18.53 - $31.5 $161,359 - $274,302
8,708 New
8,708 $269,000
Q2 2020

Aug 13, 2020

SELL
$8.5 - $15.82 $126,293 - $235,053
-14,858 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$7.25 - $19.22 $23,055 - $61,119
-3,180 Reduced 17.63%
14,858 $136,000
Q4 2019

Feb 06, 2020

SELL
$13.77 - $19.2 $14,072 - $19,622
-1,022 Reduced 5.36%
18,038 $314,000
Q2 2019

Aug 13, 2019

BUY
$15.01 - $18.89 $45,030 - $56,670
3,000 Added 18.68%
19,060 $360,000
Q4 2018

Jan 25, 2019

SELL
$10.77 - $18.44 $53,742 - $92,015
-4,990 Reduced 23.71%
16,060 $279,000
Q3 2018

Oct 26, 2018

BUY
$9.1 - $14.8 $27,755 - $45,140
3,050 Added 16.94%
21,050 $298,000
Q1 2018

May 08, 2018

SELL
$5.7 - $12.3 $40,926 - $88,314
-7,180 Reduced 28.51%
18,000 $179,000
Q4 2017

Feb 13, 2018

BUY
$3.65 - $5.98 $13,067 - $21,408
3,580 Added 16.57%
25,180 $137,000
Q3 2017

Nov 13, 2017

BUY
$3.0 - $6.0 $64,800 - $129,600
21,600
21,600 $130,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.48B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Dorsey & Whitney Trust CO LLC Portfolio

Follow Dorsey & Whitney Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.